Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution

American Journal of Clinical Pathology

Volumn 117, Issue 2, 2002, Pages 188-193

  Hornick, Jason L ^a   Fletcher, Christopher D M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CD117; GIST; Immunohistochemistry; KIT; Sarcoma; STI571

Indexed keywords

STEM CELL FACTOR;

ANGIOSARCOMA; ANTIGEN DETECTION; ARTICLE; CHONDROSARCOMA; CLEAR CELL SARCOMA; CONTROLLED STUDY; DENDRITIC CELL; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EWING SARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEIOMYOSARCOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MELANOMA; NERVE SHEATH TUMOR; NEURILEMOMA; NEUROECTODERM TUMOR; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; STANDARDIZATION; SYNOVIAL SARCOMA;

CHONDROSARCOMA; DIAGNOSIS, DIFFERENTIAL; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; NEURILEMMOMA; NEUROECTODERMAL TUMORS, PRIMITIVE; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-KIT; SARCOMA; SARCOMA, EWING'S; SARCOMA, SYNOVIAL;

EID: 0036319991     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/LX9U-F7P0-UWDH-8Y6R     Document Type: Article

References (30)

1. CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34
2. Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal
3. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases
4. Requirement of c-kit for development of intestinal pacemaker system
5. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: Immunohistochemical study on formalin-fixed, paraffin-embedded tissues
6. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity
7. Paraffin section detection of the c-kit gene product (CD117) in human tissues: Value in the diagnosis of mast cell disorders
8. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors
9. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
10. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors
11. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas
12. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors
13. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors: A study of 200 cases
14. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
15. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
16. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor
17. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
18. Evaluation of the safety and efficacy of an oral molecularly-targeted therapy, STI571, in patients with unresectable or metastatic gastrointestinal stromal tumors (GISTs) expressing c-kit (CD117)
19. STI571, an active drug in metastatic gastrointestinal stromal tumors (GIST), an EORTC phase I study
20. KIT expression in angiosarcomas and fetal endothelial cells: Lack of mutations of exon 11 and exon 17 of c-kit
21. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT)
22. Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall
23. Enzinger and Weiss's Soft Tissue Tumors. 4th ed.
24. Diagnostic Histopathology of Tumors. 2nd ed.
25. Proto-oncogene c-kit expression in malignant melanoma: Protein loss with tumor progression
26. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential
27. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis
28. c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells
29. The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit
30. Are desmoid tumors kit positive